logo
Government pledges to ‘transform care' for people with ME

Government pledges to ‘transform care' for people with ME

Yahoo3 days ago
The Government has pledged to give hundreds of thousands of people living with chronic fatigue syndrome 'improved care closer to home' as it acknowledged that many patients with the condition 'struggle' to get appropriate care.
The Department of Health and Social Care said it is 'committed to changing attitudes and transforming care' for people with Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) as it prepared to publish a new plan to improve care for people with the condition.
It comes after the high-profile death of a young woman from the disease.
Maeve Boothby-O'Neill, 27, suffered with ME for a decade before she died at home in Exeter in October 2021 from severe malnutrition.
Her inquest heard how she had been admitted to the Royal Devon and Exeter Hospital three times that year for treatment for malnutrition.
The 10-day hearing focused on the final few months of her life, by which time she was confined to bed, unable to chew food and had difficulty drinking because she was not able to sit up.
Miss Boothby-O'Neill, the daughter of Sean O'Neill, a journalist with The Times newspaper, had been suffering from fatigue since the age of 13, which got worse after she completed her A-levels.
Deborah Archer, now an area coroner for Devon, Plymouth and Torbay, concluded Miss Boothby-O'Neill had died from natural causes 'because of severe myalgic encephalomyelitis (ME)'.
Last year she wrote to the Government to highlight a lack of specialist beds, 'extremely limited' training for doctors and lack of available funding for research and treatment of the condition.
On Tuesday, the Government said that it has created a plan which 'outlines clear steps to improve care for patients, by investing in research and offering access to care in the community'.
The Department of Health and Social Care (DHSC) acknowledged that many people with the condition 'currently struggle to access appropriate care tailored to their complex condition'.
The plan, which is expected to be published on Tuesday, will include new training for NHS workers, DHSC said.
And the document will also include funding for research, the DHSC said.
Public health minister Ashley Dalton, said: 'ME/CFS is a debilitating illness that can severely limit patients' ability to participate in everyday activities, maintain employment, or enjoy family and social life.
'Today's plan will help tackle the stigma and lack of awareness of this condition through improved training for NHS staff.
'And through our neighbourhood health services, we will ensure patients suffering from the effects of ME/CFS can access quality care, closer to home, as pledged in our 10-Year Health Plan.
But Action for ME said that the plan 'does not go far enough'.
Sonya Chowdhury, chief executive of the charity, said: 'We appreciate the time DHSC has put into the delivery plan and their engagement with us and the ME community throughout.
'However, the plan simply does not go far enough. We are at the stage now where we need more than rhetoric, we need to take a strategic approach if we want a different outcome. What is proposed in the plan will not offer this.
'We must have a funded, dedicated research hub to leverage our world-leading life sciences sector to unlock treatments and ultimately cures for ME.
'Without a commitment to better co-ordinate research, people with ME will continue to be neglected, overlooked and, for many, confined to their homes.
'ME charities have been calling for this funding to be accelerated for years and we are still not seeing a strategic approach to address this historic shortfall. Once again, it feels like people with ME have been ignored.'
Dr Charles Shepherd, honorary medical advisor and trustee at the ME Association, said: 'Whilst today's announcement is an important step forward in helping to improve the quality of life of people with ME/CFS, the Government must now go much further to improve their medical care and management and help to fund much needed biomedical research into cause and treatment.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Pilots killed in Southend Airport plane crash named
Pilots killed in Southend Airport plane crash named

Yahoo

time5 minutes ago

  • Yahoo

Pilots killed in Southend Airport plane crash named

Two pilots killed when a plane crashed at Southend Airport earlier this month have been named. They were captain Danny Marco Franken and first officer Floris Christiaan Rhee, said flight operator Zeusch Aviation. They are believed to be Dutch. The chartered plane, which had taken a patient to the UK for treatment, crashed shortly after take-off at the airport on 13 July. It's thought the patient had been dropped off and the aircraft was heading back to base in the Netherlands. Two passengers, a female nurse and a male doctor, also died. Zeusch Aviation boss Marco Rietvelt said the pilots were "highly skilled". "Their passion for flying was matched by their dedication to their colleagues and the important missions they carried out," said a statement. "We are all deeply shocked and saddened by this tragic loss. "Our priority is to support the families of those lost, as well as our employees, during this incredibly difficult time. "We are also fully committed to assisting the authorities in their ongoing investigation." The nurse who died was named in reports as 31-year-old Maria Fernanda Rojaz Ortiz, originally from Chile, and the doctor was named as German national Dr Matthias Eyl, 46. The UK's Air Accidents Investigation Branch is investigating. Read more from Sky News: John Johnson, who was at the airport with his wife and children, said the Beechcraft Super King Air 200 crashed soon after take off. "It took off and about three or four seconds [later] it started to bank heavily to its left, and then within a few seconds of that happening, it more or less inverted and crashed just head first into the ground," he said. The pilots had waved at his family moments earlier as they taxied the plane to the take-off position, Mr Johnson said. Zeusch Aviation is based at Lelystad Airport in the Netherlands.

Agilent Technologies' Q3 2025 Earnings: What to Expect
Agilent Technologies' Q3 2025 Earnings: What to Expect

Yahoo

time5 minutes ago

  • Yahoo

Agilent Technologies' Q3 2025 Earnings: What to Expect

Santa Clara, California-based Agilent Technologies, Inc. (A) is a global leader in providing application-focused solutions to the life sciences, diagnostics, and applied chemical markets. Valued at a market cap of $33.9 billion, the company designs and manufactures a broad portfolio of analytical instruments, software, consumables, and services. It is scheduled to announce its fiscal Q3 earnings for 2025 after the market closes on Wednesday, Aug. 27. Before this event, analysts project this healthcare company to report a profit of $1.37 per share, up 3.8% from $1.32 per share in the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in each of the last four quarters. Its earnings of $1.31 per share in the previous quarter outpaced the consensus estimates by 4%. More News from Barchart NVDA Broken Wing Butterfly Trade Targets A Profit Zone Between 150 and 160 Is Opendoor Stock a Buy at New 52-Week Highs? Billionaire Peter Thiel is Betting Big on Stablecoins. Should You Buy the "MicroStrategy of Ethereum," Too? Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. For the full year, analysts expect A to report EPS of $5.59, up 5.7% from $5.29 per share in fiscal 2024. Furthermore, its EPS is expected to grow 8.8% year-over-year to $6.08 in fiscal 2026. A has fallen 8.6% over the past 52 weeks, underperforming both the S&P 500 Index's ($SPX) 14.5% return and the Health Care Select Sector SPDR Fund's (XLV) 8.3% loss over the same time frame. Agilent Technologies reported impressive Q2 performance on May 28, and its shares surged 2.2% in the following trading session. Due to growth in its life sciences and diagnostics markets revenue and a rise in CrossLab segment's sales, the company's overall revenue improved 6% year-over-year to $1.7 billion, topping consensus estimates by 2.5%. Moreover, its adjusted EPS of $1.31 advanced 7.4% from the prior-year quarter, exceeding Wall Street expectations by 4%. A's effective Ignite Transformation initiative supported its Q2 results. Looking ahead to fiscal 2025, A expects revenue to range between $6.7 and $6.8 billion, and projects adjusted EPS in the range of $5.54 to $5.61. Wall Street analysts are moderately optimistic about A's stock, with an overall "Moderate Buy" rating. Among 16 analysts covering the stock, eight recommend "Strong Buy," and eight advise 'Hold.' The mean price target for A is $138.57, indicating a 16% premium from the current levels. On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on

UnitedHealth Says It's Cooperating With DOJ Medicare Probes
UnitedHealth Says It's Cooperating With DOJ Medicare Probes

Bloomberg

time7 minutes ago

  • Bloomberg

UnitedHealth Says It's Cooperating With DOJ Medicare Probes

By Updated on Save UnitedHealth Group Inc. is responding to criminal and civil requests from the US Department of Justice about its Medicare practices, the company said, confirming reports of probes that surfaced over the last two years. The company is cooperating with the department, UnitedHealth said. The company reached out to the Justice Department after reports of the probes surfaced, and received the requests after reaching out, the company said in a filing Thursday.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store